Inventor
HECHLER TORSTEN
DE15 patents
⚠️ This page may combine multiple inventors who share the name “HECHLER TORSTEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HEIDELBERG PHARMA RES GMBH
13 patentsUS11583569B2Feb 21, 2023
PSMA-targeting amanitin conjugates
HEIDELBERG PHARMA RES GMBH2 citations69
US11926631B2Mar 12, 2024
Method of treating cancer using amanitin derivatives
HEIDELBERG PHARMA RES GMBH0 citations61
US11702451B2Jul 18, 2023
Method for synthesizing amanitins
HEIDELBERG PHARMA RES GMBH0 citations61
US11420971B2Aug 23, 2022
Method for synthesizing amanitins
HEIDELBERG PHARMA RES GMBH1 citations61
US10961277B2Mar 30, 2021
Method for synthesizing amanitins
HEIDELBERG PHARMA RES GMBH1 citations61
US12576158B2Mar 17, 2026
Antibody drug conjugates with cleavable linkers
HEIDELBERG PHARMA RES GMBH0 citations60
US12201693B2Jan 21, 2025
Amanitin conjugates
HEIDELBERG PHARMA RES GMBH0 citations60
US11590238B2Feb 28, 2023
Amanitin conjugates
HEIDELBERG PHARMA RES GMBH1 citations60
US11446388B2Sep 20, 2022
Amanitin antibody conjugates
HEIDELBERG PHARMA RES GMBH1 citations59
US12595284B2Apr 7, 2026
Amatoxin antibody-drug conjugates and uses thereof
HEIDELBERG PHARMA RES GMBH0 citations58
US12544419B2Feb 10, 2026
Targeted amatoxin conjugate for the treatment of solid tumors
HEIDELBERG PHARMA RES GMBH0 citations50
US12403201B2Sep 2, 2025
B-lymphocyte specific amatoxin antibody conjugates
HEIDELBERG PHARMA RES GMBH0 citations50
US11976131B2May 7, 2024
Humanized antibodies against PSMA
HEIDELBERG PHARMA RES GMBH0 citations50